Sustained T Cell Immunity, Protection and Boosting Using Extended Dosing Intervals of BNT162b2 mRNA Vaccine (2021)

First Author: Payne R
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2139/ssrn.3891065

Publication URI: http://dx.doi.org/10.2139/ssrn.3891065

Type: Journal Article/Review

Parent Publication: SSRN Electronic Journal